Price
CHART BY
Frequently asked questions
What is the Earnings Per Share (EPS) for Centogene?
What are the analyst ratings and target price for Centogene's stock?
What is Centogene's revenue over the trailing twelve months?
What is the EBITDA for Centogene?
What is the free cash flow of Centogene?
How many employees does Centogene have, and what sector and industry does it belong to?
Financials
- EPS (TTM)
- -1.371
- Revenue (TTM)
- €52.48M
- EBITDA (TTM)
- -€36.18M
- Free Cashflow (TTM)
- -€40.86M
Analyst Ratings
The price target is €1.50 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
- Employees
- 493
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- NL0014040206
- Primary Ticker
- CNTG